Combating diabetic nephropathy with drug therapy (Q35087369)

6 August 2017

1 reference

title

Combating diabetic nephropathy with drug therapy (English)

1 reference

6 August 2017

1 reference

Martins D

1

1 reference

6 August 2017

Norris K

series ordinal

2

1 reference

6 August 2017

language of work or name

1 reference

1 October 2001

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

148-156

1 reference

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Renal Factors Influencing Blood Pressure Threshold and Choice of Treatment for Hypertension in IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Pharmacologic therapy for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-001-0027-5

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis

1 reference

12 December 2020

Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glucosylated proteins

1 reference

12 December 2020

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

1 reference

12 December 2020

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

12 December 2020

The kidney in diabetes: how to control renal and related cardiovascular complications

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

12 December 2020

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

12 December 2020

Increased aggregation of human platelets produced by advanced glycation end products in vitro

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men

1 reference

12 December 2020

Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Nephropathy in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

12 December 2020

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

1 reference

12 December 2020

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling

1 reference

12 December 2020

Early glycosylation products induce glomerular hyperfiltration in normal rats

1 reference

12 December 2020

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group

1 reference

12 December 2020

The renoprotective effect of antihypertensive drugs.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

12 December 2020

Effect of an alpha-adrenergic blocker, and ACE inhibitor and hydrochlorothiazide on blood pressure and on renal function in type 2 diabetic patients with hypertension and albuminuria. A randomized cross-over study

1 reference

12 December 2020

Influence of the angiotensin converting enzyme inhibitor cilazapril, the beta-blocker propranolol and their combination on haemodynamics in hypertension

1 reference

12 December 2020

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

12 December 2020

Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria

1 reference

12 December 2020

Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark

1 reference

12 December 2020

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

1 reference

12 December 2020

Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study.

1 reference

12 December 2020

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

1 reference

12 December 2020

Risk factors for nephropathy in type 2 diabetes mellitus

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11892-001-0027-5

Identifiers

DOI

1 reference

6 August 2017

1 reference